Background: The purpose of the present study is to investigate the expression levels of STAT3, pSTAT3, MMP-7 and VEGF in colorectal adenocarcinoma, and also to determine association with the clinico-pathological parameters and co-expression of these genes. Methods: An immunohistochemical method was used to evaluate the expression of MMP-7 and VEGF genes in 93 archival tissues whereas STAT3 and pSTAT3 expression was determined in 75 cases. Results: Overexpression of STAT3 was detected in 26.7% (20/75), pSTAT3 in 13.4% (10/75), MMP-7 in 38.8% (36/93) and VEGF in 59.2% (55/93) of the colorectal carcinomas. STAT3, MMP-7 and VEGF immunopositivity were significantly correlated with poorly-differentiated tumors (P = 0.004; P = 0.03; P = 0.002, respectively) but not with other parameters. However, pSTAT3 immunostaining was not significantly associated with the clinico-pathological characteristics. Significant relationship was noted between overexpression of pSTAT3 and STAT3 (P < 0.001), pSTAT3 and VEGF (P = 0.044), pSTAT3 and MMP-7 (P = 0.003), and STAT3 and VEGF (P = 0.037) but marginal association was detected between STAT3 and MMP-7 (P = 0.057), and MMP-7 and VEGF (P = 0.052). Conclusion: Our data suggest that expression of these genes may have an important role in tumor dedifferentiation and may be useful as indicators of biologic aggressiveness. Co-expression of the bio-* Corresponding author.
for histological evaluation and immunohistochemical studies. The clinico-pathological data including patients' gender, age, ethnic group, tumor grade and Dukes' stage were obtained from the surgical and pathological records of each patient ( Table 1) . The tumors were staged according to the Dukes' staging classification A, B, C and D. Tumors were histologically graded as well (Grade I), moderate (Grade II), and poorly (Grade III) differentiated based on the predominant pattern of the tumor by a qualified pathologist.
Immunohistochemistry
The tissue sections of 4 μm thickness were cut from each paraffin-embedded tumor tissue blocks and placed on the glass slides. These blocks were obtained from the hospitals. These sections were immunostained with primary antibodies directed against STAT3 (rabbit anti-human, IgG H-190; polyclonal, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), pSTAT3 (rabbit anti-human IgG Tyr705; polyclonal, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), MMP-7 (rabbit anti-human, IgG/PUMP-1; polyclonal, Chemicon International, Temecula, CA, USA) and VEGF (mouse anti-human, IgG 2a C-1; monoclonal, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), using standard immunoperoxidase method. All the procedures were performed at room temperature, unless otherwise specified. DAKO Envision™, Peroxidase, Mouse kit (Dako, Glostrup, Denmark) was used to detect the reaction of mouse anti-human antibody for VEGF, and Dako Cytomation Envision System-HRP Labelled Polymer Anti-Rabbit (Dako, Glostrup, Denmark) was used to demonstrate the reaction of rabbit anti-human against STAT3, pSTAT3 and MMP-7 proteins.
The tissue sections were deparaffinized in xylene, rehydrated in decreasing concentration of ethanol and rinsed in distilled water. After a brief wash, the sections were subjected to microwave antigen retrieval treatment (40.9) to obtain optimal staining intensity. The sections were microwaved in 10 mM citrate buffer (pH 6.0) solution for STAT3, pSTAT3 and VEGF. The solution was allowed to boil for 5 minutes twice and then cooled down to the room temperature before washing the sections with the distilled water. Following the treatment, the sections were incubated with 3% hydrogen peroxide in water for 10 minutes at 37˚C to block the endogeneous peroxidase activity. The slides were washed with distilled water and phosphate-buffered saline (PBS) pH 7.4 for 5 minutes each. The tissue sections were incubated with anti-STAT3 (dilution 1:150), anti-pSTAT3 (1:200), anti-MMP-7 (1:50) and anti-VEGF (1:50) for 1 hour at room temperature in a humidified chamber. All the antibodies were diluted in 1% BSA (bovine serum albumin, Sigma, St Louis, Missouri, USA). The slides were washed in PBS for 30 minutes. The sections were incubated with horseradish-peroxidase labelled polymer for 30 minutes at room temperature and rinsed with PBS for 5 minutes. The reactions were treated with DAB (3, 3 diaminobenzidine) chromogen (Dako, Glostrup, Denmark) until appropriate colour intensity was reached. The sections were counterstained with Harris haematoxylin for STAT3, pSTAT3, MMP-7 and VEGF by dipping for 4 seconds. The slides were mounted in Depex and examined under the light microscope (Leica, Germany). Colorectal carcinoma tissues positive for these markers were routinely used as positive controls. For negative control, the primary antibodies were substituted with PBS.
Evaluation of Immunostaining and Statistical Analysis
Tumor cells that exhibit cytoplasmic and/or nuclear immunoreactivity were considered as positive for STAT3 and pSTAT3. Immunostaining present in the cytoplasm of the malignant cells was regarded as positive for MMP-7 and VEGF protein expression. The scoring of the tissue sections was based on the percentage of the stained tumor cells [24] . The expression of STAT3, pSTAT3, MMP-7 and VEGF was based on the percentage of malignant cells stained: 0% -10% as negative; 11% -25% as weakly positive, and equal or more than 26% as strongly positive or overexpressed. Weakly positive and negative tumors were not included in the statistical analysis. All statistical analyses were carried out by using SPSS (version 11.5, USA). Association between expression of the biomarkers and clinico-pathological parameters was determined by nonparametric test. Since the normality of the data was violated, the nonparametric test namely Mann-Whitney for paired parameters (age at diagnosis, gender, lymph node status) or Kruskall-Willis for categorical data (ethnicity, histological grade, Dukes' stage) were used. The significance of co-expression of the biomarkers was analysed by Fisher's exact test. Statistical significance was set at P < 0.05.
Results
The immunostaining of STAT3 (Figure 1(a) ) and pSTAT3 (Figure 1(b) ) exhibited heterogeneous staining pattern. Expression of STAT3 was present either in the cytoplasm or nuclear region in colorectal tumor cells; occasional staining was present in both areas. However, pSTAT3 immunoreactivity appeared to be predominant in the nuclear region, whereas the cytoplasmic area showed very weak immunostaining. However, intratumor observation showed some heterogeneous immunoreactivity. MMP-7 (Figure 1 Statistical analysis was performed to evaluate the relationship between STAT3, pSTAT3, MMP-7 or VEGF immunoreactivity and clinico-pathological parameters such as patients' age, gender, ethnic group, histological grade, Dukes' stage and nodal status ( Table 2 and Table 3 ). STAT3, MMP-7 and VEGF immunopositivity were significantly correlated with poorly-differentiated tumors (P = 0.004; P = 0.03; P = 0.002, respectively) but not with other parameters. However, pSTAT3 immunostaining was not significantly associated with the clinico-pathological characteristics. Elevated expression of STAT3, MMP-7 and VEGF was demonstrated in 44.8%, 41.7% and 72.2% of the poorly-differentiated tumors, and 30.0%, 56.0% and 72.0% of the moderately-differentiated tumors compared to 3.8%, 21.9% and 34.4% of the well-differentiated tumors, correspondingly. Co-expression between STAT3, pSTAT3, MMP-7 and VEGF genes was also analysed ( Table 4) . Significant relationship was noted between overexpression of pSTAT3 and STAT3 (P < 0.001), pSTAT3 and VEGF (P = 0.044), pSTAT3 and MMP-7 (P = 0.003), and STAT3 and VEGF (P = 0.037) but marginal association was detected between STAT3 and MMP-7 (P = 0.057), and MMP-7 and VEGF (P = 0.052).
Discussion
In the present study we have examined the expression of STAT3, pSTAT3, MMP-7 and VEGF protein by immunohistochemistry in a cohort of colorectal adenocarcinomas. There was overexpression of STAT3 in 26.7% of CRCs but smaller proportion (13.4%) of the tumors demonstrated the activated form of STAT3 (pSTAT3). Similarly Hbibi et al. noted that 62% and 27% of 126 CRCs were positive for STAT3 and pSTAT3, respectively [25] . Other investigators reported that the frequencies of overexpressed tumors range from 44% -78% [4] [28] . Significant correlation was noted between increased expression of STAT3 and the phosphorylated form of STAT3 which is in agreement with findings by Lassman et al. [29] . Interestingly our data showed lower frequency of pSTAT3 overexpression among the CRCs compared to other findings which could be attributed to scoring methods, random selection of patients and types of antibodies used. Our findings suggest that a proportion of the tumors that overexpress STAT3 might harbour higher levels of pSTAT3 which could have important implications in colorectal cancer biology.
Increased expression of STAT3 was significantly associated with high grade tumors but this was not seen for the phosphorylated form of STAT3. Although the association was not supported statistically, higher frequency of poorly-differentiated tumors (24.1%) was positive for pSTAT3 compared to moderately (10.0%) and well (3.8%) differentiated tumors. Overexpression of STAT3 and pSTAT3 was not associated with other clinico-pathological parameters such as age, gender, ethnicity, Dukes' classification and nodal metastases. Contrary to our results, some studies showed significant correlation between pSTAT3 and presence of nodal metastases [4] [9] showed that all the well (n = 6), moderately (n = 27) and poorly-differentiated (n = 3) tumors were positive for both the activated and unactivated form of STAT3 protein [28] . Though constrasting results were noted probably due to smaller sample size, our data suggests that upregulation of STAT3 and pSTAT3 in CRC could have an important role in the tumor progression as defined by its association with high grade tumors. MMP-7 is widely expressed in the epithelial tumor cells of malignant colorectal adenocarcinomas and believed to be associated with metastasis [13] [14] [30] [31] . In the current study we found that MMP-7 was overexpressed in 38.8% of CRCs and this positive rate is comparable with previous reports of 30% to 46% [15] [17] [30] [32] . In a recent study with a larger sample size of 620 cases, Fang et al. reported MMP-7 immunopositivity in 88.8% of the cancer [33] . Roca and co-investigators demonstrated 81.7% of 60 CRC tumors were positive for MMP-7 [34] . In the present study, clinico-pathological analysis demonstrated that the frequency of MMP-7 immunopositivity was significantly higher in moderately-and poorly-differentiated tumors compared to welldifferentiated tumors. However, earlier studies did not observe such association [17] [34] . Some of the studies have evaluated expression of MMP-7 in association with clinico-pathological parameters but did not correlate with histological grade [15] [30] [32] [33] . There was no significant association between MMP-7 expression and Represents significance at P < 0.05; Note: S, significant at P < 0.05. NS, not significant. Table 4 . Association between STAT3, pSTAT3, MMP-7 and VEGF protein expression in colorectal adenocarcinoma patients. Note: S, significant at P < 0.05. NS, not significant.
the age, gender, ethnicity, Dukes' staging and lymph node status of the patients. Roca and coauthors found no significant correlation between MMP-7 and lymph node metastases which is consistent with our findings [34] . In contrast, Adachi and co-investigators reported that elevated levels of MMP-7 was significantly associated with lymph node metastases and advanced Dukes' stage suggesting its role in tumor metastases [15] [30]. Our findings suggest that overexpression of MMP-7 could be a biological indicator for aggressive characteristics of colorectal cancer. VEGF has been extensively investigated in relation to the development of novel drugs against CRCs [20] . In the current study, elevated levels of VEGF were demonstrated in 59.2% of CRC. Among the biomarkers evaluated in this study, VEGF immunopositivity was the most frequent in CRC. In a series of studies, overexpression of VEGF was detected in 45% to 70% of CRCs [21] [35]- [42] which is comparable with the present study. However, Khorana et al. reported lower incidence of VEGF immunopositivity (34%) [43] whereas Uner et al. showed higher frequency of 86% in CRCs [44] . In the present study, a significant association was observed between VEGF expression and high histological grade tumors. Although consistent with other published reports [40] Apart from determining the frequencies of the genes overexpressed as well as correlation with clinico-pathological parameters we also determined co-overexpression of STAT3, pSTAT3, MMP-7 and VEGF in CRCs. Overexpression of STAT3 was significantly associated with VEGF but showed marginal correlation with MMP-7. However, the activated form of STAT3 was found to be significantly associated with MMP-7 and VEGF. Our data also showed that elevated levels of MMP-7 was marginally associated VEGF. Earlier studies have reported that pSTAT3 promotes tumor angiogenesis by acting as a direct transcriptional activator of VEGF and mediates expression of genes related to tumor growth and metastasis [6] . Recently, Cascio and co-investigators supported this evidence in colon cancer cells by demonstrating the binding of STAT3 to the promoter of VEGF [47] . Elevated levels of MMP-7 mRNA was detected in colorectal tumor tissues with activated form of STAT3 [3] . In addition to MMP-7, aberrant activity of STAT3 could be a major factor of local tumor progression and metastasis of colorectal cancer through upregulation of other MMPs including MMP-1, MMP-3 and MMP-9 [3] . This could also explain the reason that we noted pSTAT3 was significantly associated with MMP-7 but STAT3 showed marginal association with MMP-7.
Among the MMPs (MMP-1, MMP-2, MMP-3, MMP-7, MMP-9 and MMP-13), MMP-7 is primarily expressed in cancer cells during tumor progression [48] and implicated in promoting angiogenesis by remodeling the ECM [49] . Ito et al. reported that despite increased expression of VEGF, upregulation of MMP-7 in addition to MMP-1 and MMP-3 may regulate the switch from vascular quiescence to angiogenesis in the human colorectal tissues [50] . Furthermore, high levels of MMP-7, MMP-1 and MMP-3 along with VEGF is associated with increased expression of angiogenesis markers in the CRC suggesting that MMP-7 could be one of the regulators of VEGF activity in human colorectal cancer cells. These observations support our data that demonstrated marginal association between MMP-7 and VEGF.
The possible reasons for the differences between the studies could be attributed to the sample size of the cases used in the investigations, scoring methods including variations in the threshold definitions for overexpression between the laboratories, selection bias with regard to recruitment of patients such as patients' characteristics, ethnicity, different histopathological types of the tumors and antibodies used. These differences could alter the distribution of the immunopositivity that might influence the statistical power to determine the significance of association.
In our study, we showed an interesting observation that STAT3, MMP-7 and VEGF were consistently associated with high grade tumors. Histological grade or tumor differentiation has been regarded as one of the predictive factors associated with poor prognosis for colorectal carcinomas. Furthermore we have also demonstrated significant correlation between pSTAT3 and VEGF or MMP-7, with marginal association between VEGF and MMP-7.
Conclusion
In conclusion, our data suggest that expression of these genes may have an important role in tumor dedifferentiation and may be useful indicators of biologic aggressiveness. Co-expression of the biomarkers by cancer cells might have important implications in colorectal cancer biology and could be useful biological markers of the malignant phenotype.
